Piperlongumine reverses doxorubicin resistance through the PI3K/Akt signaling pathway in K562/A02 human leukemia cells
2015 ◽
Vol 9
(4)
◽
pp. 1345-1350
◽
Keyword(s):
2019 ◽
Vol 20
(7)
◽
pp. 989-998
◽
Keyword(s):
2017 ◽
Vol 36
(1)
◽
Keyword(s):
2017 ◽
Vol 14
(4)
◽
pp. 3067-3073
◽
Keyword(s):
Keyword(s):
2016 ◽
Vol 48
(8)
◽
pp. 750-755
◽
Keyword(s):